Innovent Biologics, Inc.

27
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG4818G1010
HKD
80.95
-1.6 (-1.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Innovent Biologics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,014.00
-40.00
-1,264.00
-2,523.00
-3,183.00
-964.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
8,616.00
437.00
445.00
360.00
-110.00
-375.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
11,084.00
1,978.00
360.00
-2,228.00
-2,352.00
-260.00
Cash Flow from Investing Activities
-7,497.00
-2,763.00
-1,508.00
-2,035.00
-2,227.00
-5,880.00
Cash Flow from Financing Activities
5,231.00
-524.00
2,999.00
3,485.00
6,125.00
5,571.00
Net Cash Inflow / Outflow
8,693.00
-1,295.00
1,844.00
-641.00
1,307.00
-1,209.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-125.00
13.00
-7.00
137.00
-237.00
-639.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Innovent Biologics, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
1014.80153226561
7104.25818631159
-6,090.00
-85.72%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
8616.04146868747
1678.37366378247
6,938.00
413.36%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
11084.8211876695
8620.08999443037
2,464.00
28.59%
Cash Flow from Investing Activities
-7497.1289464026
-9071.60093317636
1,574.00
17.36%
Cash Flow from Financing Activities
5231.42514406506
1685.47946090745
3,546.00
210.38%
Net Cash Inflow / Outflow
8693.76166700356
1178.02880669959
7,515.00
637.99%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-125.355718328345
-55.939715461873
-70.00
-124.09%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 460.19% vs 448.47% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
11,084.82
1,978.78
460.19%